Geneva, July 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127873) titled 'Prospective, Multicenter, Single-Arm Phase II Clinical Study of Sacituzumab Tirumotecan (SKB264) in Patients with Previously Treated Advanced Biliary Tract Malignancies' on July 9.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: The Affiliated Hospital of Xuzhou Medical University

Condition: biliary tract cancer

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-07-09

Target Sample Size: Intervention group:37;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=331971

Disclaimer: Curated by HT Syndica...